Orange Book product · Generic (ANDA)
VORICONAZOLE
VORICONAZOLE
At a glance
Aug 08, 2016
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 08, 2016
10 yr ago
Today
Pharmaceutical detail
Active ingredient
VORICONAZOLE
Strength
50MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 206654
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of VORICONAZOLE
- 2017VORICONAZOLEBrand (NDA)
NDA 208562 · HIKMA
- 2003VFENDBrand (NDA)
NDA 021630 · PF PRISM CV
- 2002VFENDBrand (NDA)
NDA 021267 · PF PRISM CV
- 2002VFENDBrand (NDA)
NDA 021266 · PF PRISM CV
- 2026VORICONAZOLEGeneric (ANDA)
ANDA 220078 · ZHEJIANG NOVUS
- 2025VORICONAZOLEGeneric (ANDA)
ANDA 220043 · HAINAN POLY PHARM
- 2025VORICONAZOLEGeneric (ANDA)
ANDA 211598 · HETERO LABS LTD V
- 2024VORICONAZOLEGeneric (ANDA)
ANDA 218533 · ASPIRO
- 2024VORICONAZOLEGeneric (ANDA)
ANDA 216805 · ZHEJIANG POLY PHARM
- 2023VORICONAZOLEGeneric (ANDA)
ANDA 211264 · UBI
- 2023VORICONAZOLEGeneric (ANDA)
ANDA 212162 · EUGIA PHARMA
- 2022VORICONAZOLEGeneric (ANDA)
ANDA 210849 · PHARMOBEDIENT
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
